1h Free Analyst Time
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Hematology Testing Market ReportSpeak directly to the analyst to clarify any post sales queries you may have.
The hematology testing market size was valued at USD 3,384.34 million in 2021 and is expected to reach USD 4,409.22 million by 2027, growing at a CAGR of 4.51% during the forecast period
HEMATOLOGY TESTING MARKET OVERVIEW
The growth of the market can be attributed to the high prevalence/incidence of several acute, chronic, and infectious diseases, especially blood-related ailments. An increased number of programmed parameters in the hematology analyzers have increased their scope of usage in various new health condition diagnostics. The conventional methods are very expensive for the rare blood-related disorders in the market. There is a huge scope for hematology testing in the new disease conditions.
The following factors are likely to contribute to the growth of the hematology testing market -
- Artificial Intelligence in Hematology Testing
- Increase in Demand for Point of Care Hematology Testing
- Technological Advancements in Hematology Testing
- Increased Adoption of Telehealth
- Increasing Product Launches
- Integration of Flow-Cytometry with Hematology Analysers
- Increasing Blood Transfusions & Donations
KEY HIGHLIGHTS
- At least once in a lifetime, 70% of the population will undergo the CBC test. The scope of CDC is increasing for various new diagnostics. This will drive the market largely.
- Due to the shortage of physicians and other benefits through the telehealth platforms, the hospitals are largely adopting telehealth. This scenario has a major impact on the hematology market. The doctors prescribe the tests, the patients are preferring to undergo tests in the nearby smaller diagnostic labs or physician offices and share the results in the telehealth platform.
HEMATOLOGY TESTING MARKET SEGMENTS
The hematology pumps market research report has the following segmentation
- Product
- Analyzer Part
- Analyzer volume
- Tests
- End-user
- Geography
HEMATOLOGY TESTING MARKET SEGMENTATION
- The usage of 5-part hematology analyzers is increasing because there is a huge demand for automated analyzers which provides the readymade results for various programmed parameters required in the lab.
- Routine hematology tests performed are increasing over time. The parameters checked in the routine hematology tests are used for various health conditions. Development in technological advancements has led to an understanding of the relationship between routine tests and various disease indications. This has increased the number of routine tests performed in the world.
Market Segmentation by Product
- Consumables
- Analyzer
Market Segmentation by Analyzer-Part
- 5&6 Part
- 3-Part
Market Segmentation by Analyzer-Volume
- Small & Medium Volume
- High Volume
Market Segmentation by Tests
- Routine
- Speciality
Market Segmentation by End-user
- Hospitals
- Standard Laboratory
- Blood Banks
- Others
GEOGRAPHICAL ANALYSIS
- North America: The demand is mainly growing across the professional healthcare settings to treat the rising patient population. Moreover, an increase in the prevalence of various blood-related disorders such as anemia, sickle cell disease, and thalassemia, especially in the US and Canada as well as the growing requirement for hematology testing is boosting the demand for hematology analyzers and consumables.
- Europe: The demand for advanced and fully automated hematology analyzers is expected to increase due to the rise in the prevalence of the target population requiring hematological tests, increased focus on technological advancements, the shift towards automation in hematology analyzers.
Market Segmentation by Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Spain
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- South Africa
VENDOR LANDSCAPE
- The key players in the hematology testing market are Abbott, Boule Diagnostics, Horiba, Sysmex, Shenzhen Mindray, Siemens Healthiness, NIHON KOHDEN, Diatron, Danaher.
Key Vendors
- Abbott
- Boule Diagnostics
- Horiba
- Sysmex
- Shenzhen Mindray Bio-Medical Electronics
- Siemens Healthineers
- Nihon Kohden
- Diatron
- Danaher
Other Prominent Vendors
- Alpha Scientific
- Agappe Diagnostics
- Analyticon Biotechnologies
- Balio Diagnostics
- B&E BIO-TECHNOLOGY
- Biosystems
- Bioway Biological Technology
- Bio-Rad Laboratories
- Clindiag Systems
- Contech Medical Systems
- Convergent Technologies
- CPC Diagnostics
- CPM Scientifica
- Diagon
- DIRUI
- Drucker Diagnostics
- Erba Diagnostics
- EDAN Instruments
- F.Hoffmann-La Roche
- Genrui Biotech
- High Technology
- Shenzhen Landwind Medical
- Linear Chemicals
- Maccura Biotechnology
- Meril Life Sciences
- Norma
- SFRI
- Shenzhen Dymind Biotechnology
- Shenzhen iCubio Biomedical Technologies
- SHENZHEN PROKAN ELECTRONICS
- SPINREACT
- Trivitron Healthcare
KEY QUESTIONS ANSWERED:
1. What is the size of the hematology testing market?
2. What are the latest trends in the global hematology diagnostic market?
3. Which region has the highest share in the hematology testing market?
4. Who are the end-users in the hematology testing market?
5. Who are the key players in the hematology testing market?
Table of Contents
1 Research Methodology2 Research Objectives3 Research Process6 Market At A Glance
4 Scope & Coverage
5 Report Assumptions & Caveats
7 Introduction
8 Market Opportunities & Trends
9 Market Growth Enablers
10 Market Restraints
11 Market Landscape
12 Product
13 Analyzers - Part Differential
14 Analyzers - Volume
15 Test
16 End-User
17 Geography
18 North America
19 Europe
20 APAC
21 Latin America
22 Middle East & Africa
23 Competitive Landscape
24 Key Company Profiles
25 Other Prominent Vendors
26 Report Summary
27 Quantitative Summary
28 Appendix
LIST OF EXHIBITS
LIST OF TABLES
Companies Mentioned
- Abbott
- Boule Diagnostics
- Horiba
- Sysmex
- Shenzhen Mindray Bio-Medical Electronics
- Siemens Healthineers
- Nihon Kohden
- Diatron
- Danaher
- Alpha Scientific
- Agappe Diagnostics
- Analyticon Biotechnologies
- Balio Diagnostics
- B&E BIO-TECHNOLOGY
- Biosystems
- Bioway Biological Technology
- Bio-Rad Laboratories
- Clindiag Systems
- Contech Medical Systems
- Convergent Technologies
- CPC Diagnostics
- CPM Scientifica
- Diagon
- DIRUI
- Drucker Diagnostics
- Erba Diagnostics
- EDAN Instruments
- F.Hoffmann-La Roche
- Genrui Biotech
- High Technology
- Shenzhen Landwind Medical
- Linear Chemicals
- Maccura Biotechnology
- Meril Life Sciences
- Norma
- SFRI
- Shenzhen Dymind Biotechnology
- Shenzhen iCubio Biomedical Technologies
- SHENZHEN PROKAN ELECTRONICS
- SPINREACT
- Trivitron Healthcare
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
